Back to search

Article

DNA-Based Deep Learning and Association Studies for Drug Response Prediction in Leiomyosarcoma

2025-10-24

Abstract excerpt

Leiomyosarcoma (LMS) is a rare and aggressive soft tissue sarcoma with limited treatment options and poor prognosis. Standard therapies, including doxorubicin, gemcitabine, trabectedin, and pazopanib, demonstrate variable efficacy across patients, underscoring the need for predictive biomarkers and computational models to inform personalized therapy. We developed a deep learning framework using DNA mutation and ex...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6cd99a2f-0e68-5b87-916b-9a1a426439b8
DOI
10.1101/2025.10.22.25338578
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
DNA-Based Deep Learning and Association Studies for Drug Response Prediction in LeiomyosarcomaDOI 10.1101/2025.10.22.25338578
Select a neighboring publication to make it the new centre.